Austin D. Kim, executive vice president, general counsel and secretary of ACADIA Pharmaceuticals Inc. Courtesy photo
The hiring of Austin Kim as GC comes just a few months after the U.S. Food and Drug Administration said it is re-evaluating ACADIA’s Nuplazid, the only drug approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.
July 20, 2018 at 12:30 PM
1 minute read
San Diego-based ACADIA Pharmaceuticals Inc. has named Austin Kim as executive vice president, general counsel and secretary.
ACADIA specializes in the development and commercialization of medicines to treat central nervous system disorders.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Predictive reporting, trend analysis, peer guidance and a practical playbook to help genetal counsels succeed in their increasingly high stakes roles as risk managers and corporate strategists
